1. Ethyl pyruvate attenuates myocardial ischemia-reperfusion injury exacerbated by hyperglycemia via retained inhibitory effect on HMGB1
- Author
-
Sarah Soh, Jae Kwang Shim, Eun Jung Shin, Young Lan Kwak, Ji Hae Jun, and Jong Wook Song
- Subjects
0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Myocardial Reperfusion Injury ,030204 cardiovascular system & hematology ,HMGB1 ,Rats, Sprague-Dawley ,Random Allocation ,03 medical and health sciences ,0302 clinical medicine ,Glycation ,Internal medicine ,medicine ,Animals ,Myocardial infarction ,HMGB1 Protein ,Pyruvates ,Saline ,biology ,business.industry ,medicine.disease ,Rats ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,Hyperglycemia ,Anesthesia ,biology.protein ,Tumor necrosis factor alpha ,Cardiology and Cardiovascular Medicine ,Ligation ,business ,Reperfusion injury ,Artery - Abstract
Background Hyperglycemia (HG) exacerbates myocardial ischemia/reperfusion (I/R) injury and renders protective strategies ineffective by amplified inflammatory response via enhanced high-mobility group box-1 (HMGB1) release. This study investigated the role of ethyl pyruvate (EP) against myocardial I/R injury under a clinically relevant HG condition. Methods Sprague-Dawley rats (n=76) were randomly assigned to 6 groups: normoglycemia (NG)-Sham, NG-I/R-control (C, saline), NG-I/R-EP treatment (50mg/kg) upon reperfusion, HG-Sham, HG-I/R-C, and HG-I/R-EP treatment upon reperfusion. HG was induced by 1.2g/kg dextrose. I/R was induced by ligation of the left anterior descending artery for 30min followed by 4h of reperfusion. Results HG resulted in exacerbation of myocardial infarct size by 19% with amplified activation of HMGB1–receptors of advanced glycation end products/toll like receptors–NF-κB pathway compared to NG following I/R, which all could be attenuated by EP. EP treatment was associated with diminished tumor necrosis factor-α, interleukin-1β, and interleukin-6 expressions. It also served to normalize the increase in pro-apoptotic Bax and the decrease in anti-apoptotic Bcl-2 protein levels. These effects were associated with decreased myocardial apoptosis and infarct size (by 30% and 36% in the NG and HG groups, respectively) regardless of the glycemic condition. Conclusion HG exacerbated myocardial I/R injury through amplified inflammatory response via increased HMGB1 level. EP treatment upon reperfusion conveyed significant myocardial protection against the I/R injury under both NG and HG conditions. Common to both glycemic conditions, associated mechanisms involved attenuated increase in HMGB1 level and suppression of its down-stream pathways.
- Published
- 2018
- Full Text
- View/download PDF